Tag Archives: Data
In Brief: More Data on Pregabalin (Lyrica) and Pregnancy
Pregabalin (marketed in the US as Lyrica) is approved by the US Food and Drug Administration for the treatment of epilepsy, fibromyalgia, and neuropathic pain. It is also used off-label to treat psychiatric disorders, most commonly generalized anxiety disorder. While it is not used as frequently as other anti-epileptic drugs, we do occasionally see women… Read More »
Brexanolone for Postpartum Depression: More Data, But Still Some Questions
In 2015, we first reported on SAGE-547 (SAGE Therapeutics), a new medication for the treatment of severe postpartum depression (PPD). SAGE-547, now called brexanolone, is an allosteric modulator of GABA-A receptors. We saw the preliminary results of the Sage Therapeutics Phase 3 Hummingbird Program earlier this year. Now we have the final set of results… Read More »
General Arthritis Data
by Rick.Ross96 Introduction Arthritis is a general term which is applied to a variety of painful conditions affecting the joints and bones. There are concerning a hundred completely different sorts of arthritis. Arthritis is often related to older folks, however it will affect people at any age, even children. This is often referred to as… Read More »